ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical devel... ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn’s disease. The company was incorporated in 2013 and is headquartered in Paris, France. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | -10.42 | -11.5201768933 | 90.45 | 90.45 | 80.03 | 500 | 80.03 | CS |
| 12 | -35.62 | -30.7998270644 | 115.65 | 126 | 71.26 | 217 | 86.86081892 | CS |
| 26 | -39.07 | -32.8043660789 | 119.1 | 128.4 | 71.26 | 223 | 105.72934335 | CS |
| 52 | 69.48 | 658.578199052 | 10.55 | 133.4 | 10.3248 | 2746 | 78.74501619 | CS |
| 156 | 60.03 | 300.15 | 20 | 133.4 | 5.81 | 2302 | 70.36491213 | CS |
| 260 | 45.77 | 133.596030356 | 34.26 | 133.4 | 5.79 | 1779 | 62.19777356 | CS |
Horsts
4分前
CommodityCoverage
4分前
JFBroderick
5分前
Zebras
6分前
panman2013
6分前
Lone Clone
6分前
MysticProdigy77
6分前
imanjen13
7分前
techno53
8分前
EisMCA2
8分前
highjumper
8分前
PickStocks
8分前
Lord Andreti
8分前
gladeshawk
8分前
theRupertPupkin
9分前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。